Stockscreener 앱 받기
4.04
1.25%
0.05
시간 외 거래:
3.91
-0.13
-3.22%
전일 마감가:
$3.99
열려 있는:
$3.99
하루 거래량:
648.08K
Relative Volume:
0.17
시가총액:
$90.70M
수익:
$32.77M
순이익/손실:
$-101.98M
주가수익비율:
-0.4204
EPS:
-9.6101
순현금흐름:
$-112.43M
1주 성능:
+6.32%
1개월 성능:
+18.13%
6개월 성능:
-6.26%
1년 성능:
-73.08%
1일 변동 폭
$3.91
$4.11
1주일 범위
$3.66
$4.11
52주 변동 폭
$1.35
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
명칭
X 4 Pharmaceuticals Inc
전화
857-529-8300
주소
61 NORTH BEACON STREET, BOSTON, MA
XFOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
4.04 | 316.07M | 32.77M | -101.98M | -112.43M | -9.6101 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-12 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2023-08-30 | 재개 | B. Riley Securities | Buy |
| 2022-12-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-12 | 개시 | Piper Sandler | Overweight |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | ROTH Capital | Buy |
| 2019-12-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-12-05 | 개시 | B. Riley FBR | Buy |
| 2019-06-07 | 개시 | Stifel | Buy |
| 2019-06-05 | 개시 | Cowen | Outperform |
모두보기
X 4 Pharmaceuticals Inc 주식(XFOR)의 최신 뉴스
Using economic indicators to assess X4 Pharmaceuticals Inc. potentialTrade Volume Report & Safe Entry Zone Identification - newser.com
Top chart patterns to watch in X4 Pharmaceuticals Inc.July 2025 Sector Moves & Safe Swing Trade Setups - newser.com
How to build a dashboard for X4 Pharmaceuticals Inc. stockWeekly Risk Summary & AI Enhanced Trading Signals - newser.com
Why X4 Pharmaceuticals Inc. stock could benefit from AI revolutionWeekly Market Summary & Reliable Intraday Trade Alerts - newser.com
Is X4 Pharmaceuticals Inc. (48Q0) stock a fit for income portfoliosDollar Strength & Free Reliable Trade Execution Plans - newser.com
What moving averages say about X4 Pharmaceuticals Inc.Earnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
Will X4 Pharmaceuticals Inc. stock benefit from commodity pricesDay Trade & Capital Efficiency Focused Strategies - newser.com
Will X4 Pharmaceuticals Inc. stock recover after recent dropPrice Action & Advanced Swing Trade Entry Plans - newser.com
What recovery options are there for X4 Pharmaceuticals Inc.Quarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Will X4 Pharmaceuticals Inc. stock benefit from AI adoptionMarket Performance Summary & AI Forecasted Entry and Exit Points - newser.com
Combining machine learning predictions for X4 Pharmaceuticals Inc.July 2025 Trends & Precise Trade Entry Recommendations - newser.com
Can volume confirm reversal in X4 Pharmaceuticals Inc.Trade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
How dovish Fed policy supports X4 Pharmaceuticals Inc. (48Q0) stockPortfolio Profit Report & Technical Entry and Exit Alerts - newser.com
X4 Pharmaceuticals Inc 48Q0 Stock Analysis and ForecastTechnical Breakout Signals & Double Digit Wealth Tips - earlytimes.in
Published on: 2025-10-28 05:23:25 - newser.com
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million - The Manila Times
X4 Pharmaceuticals Completes $155.3 Million Public Offering of Common Stock - Quiver Quantitative
X4 Pharma (NASDAQ: XFOR) closes $155.3M offering; underwriters' option fully exercised - Stock Titan
Craig Adam R buys x4 pharmaceuticals shares for $249,997 - Investing.com India
Why X4 Pharmaceuticals Inc. stock appeals to dividend seekers2025 Technical Overview & Consistent Profit Alerts - fcp.pa.gov.br
Why X4 Pharmaceuticals Inc. stock is a value investor pickJuly 2025 Gainers & Long Hold Capital Preservation Plans - Fundação Cultural do Pará
X4 Pharmaceuticals announces $145.6 million public offering of common stock - Investing.com
What candlestick patterns are forming on X4 Pharmaceuticals Inc.Earnings Overview Summary & Short-Term Swing Trade Alerts - newser.com
X4 Pharmaceuticals Bolsters Financial Stability Amid Strategic Development - StocksToTrade
X4 Pharmaceuticals Eyes Future Growth with $135 Million Offering - StocksToTrade
X4 Pharmaceuticals’ Public Offering Spurs Market Interest - timothysykes.com
X4 Pharmaceuticals (NASDAQ:XFOR) Upgraded at Zacks Research - Defense World
X4 Pharmaceuticals announces pricing of $135 million underwritten public offering at $2.90 per share - MarketScreener
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering - MarketScreener
X4 Pharmaceuticals (NASDAQ: XFOR) prices $135M offering to fund Phase 3 mavorixafor - Stock Titan
X4 Pharmaceuticals announces proposed underwritten public offering - MarketScreener
X4 Pharmaceuticals (NASDAQ: XFOR) commences equity offering; 30-day 15% option - Stock Titan
X4 Pharmaceuticals (XFOR) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Does X4 Pharmaceuticals Inc. (48Q0) stock trade below intrinsic value2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
How X4 Pharmaceuticals Inc. (48Q0) stock trades pre earningsWall Street Watch & Free Technical Confirmation Trade Alerts - newser.com
Analyzing recovery setups for X4 Pharmaceuticals Inc. investorsWeekly Profit Recap & Fast Entry Momentum Trade Alerts - newser.com
X 4 Pharmaceuticals Inc (XFOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):